U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727694) titled 'Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults' on July 09.
Brief Summary: It involves collecting safety and efficacy data, under the actual conditions of use of off label and compassionate use medicines in children and adolescents approved in humans before 2007, using a validated tool (Ennov EDC) and relying on the network recognised pediatric hemato-oncology centers in Belgium and responsible for the organization of Pediatric National tumor boards which discuss each case of relapse in order to define the best therapeutic options.
Study Start Date: July, 2026
Study Ty...